Late Survival and Long‐Term Follow‐Up After Radical Resection of Advanced Renal Cell Carcinoma With Associated Venous Tumor Thrombus
Journal of Surgical Oncology · 2025
DOI: 10.1002/jso.28020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Calvin L Chao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Vascular Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Nephrectomy, Vena Cava, Inferior. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, This study was supported by National Heart, Lung, and Blood Institute., National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Background and Objectives This study evaluates the prognostic value of venous tumor thrombus (VTT) in patients with advanced renal cell carcinoma (RCC) undergoing radical resection and inferior vena cava (IVC) thrombectomy.
Methods
Retrospective review of patients with radical nephrectomy for RCC and associated VTT (2000−2024). Patients were dichotomized into Neves 0−II (infrahepatic) and Neves III−IV groups (suprahepatic) IVC involvement for univariate analysis.
Results
A total of 64 patients (34 Neves 0−II and 30 Neves III−IV) were analyzed. No significant differences in patient or cancer characteristics. Neves III−IV was associated with greater blood loss (> 2 L) (62.1% vs. 37.9%, p = 0.02), greater intensive care unit length of stay (LOS) (4.4 vs. 1.4 days, p = 0.02), and postoperative LOS (11.0 vs. 6.5 days, p = 0.005). Overall, 30‐day mortality was only 1.6% with a mean follow‐up of 56.1 months. Local recurrence was 7.8% and IVC patency 96.9%. One‐year survival was 82.0%, 5‐year survival was 58.4%, and 15‐year survival was 42.5% without significant difference between Neves levels.
Conclusions
Radical nephrectomy with VTT thrombectomy and primary IVC repair is safe with high early survival and low local recurrence. Extent of IVC tumor thrombus extension is not a poor prognostic factor for early or late survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Division of Vascular Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- Department of Urology, Division of Urologic Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Förderung
- NHLBI NIH HHS
- This study was supported by National Heart, Lung, and Blood Institute.
- National Heart, Lung, and Blood Institute
Zitieren
APA
Chao, C. L., Reddy, N. K., Visa, M., Kundu, S. D., & Eskandari, M. K. (2025). Late Survival and Long‐Term Follow‐Up After Radical Resection of Advanced Renal Cell Carcinoma With Associated Venous Tumor Thrombus. Journal of Surgical Oncology. https://doi.org/10.1002/jso.28020
Vancouver
Chao CL, Reddy NK, Visa M, Kundu SD, Eskandari MK. Late Survival and Long‐Term Follow‐Up After Radical Resection of Advanced Renal Cell Carcinoma With Associated Venous Tumor Thrombus. Journal of Surgical Oncology. 2025. doi:10.1002/jso.28020
BibTeX
@article{Chao2025,
author = {Chao, Calvin L and Reddy, Nidhi K and Visa, Maxime and Kundu, Shilajit D and Eskandari, Mark K},
title = {Late Survival and Long‐Term Follow‐Up After Radical Resection of Advanced Renal Cell Carcinoma With Associated Venous Tumor Thrombus},
journal = {Journal of Surgical Oncology},
year = {2025},
doi = {10.1002/jso.28020}
}
EUVIMED